retatrutide fda approval timeline 2025 Availability & Retatrutide vs CagriSema: The Battle

these can appear weeks or months after starting a medication and may be harder to link to the drug

Not for everyone : Not for people with certain medical conditions (gastrointestinal issues or pancreatitis) or those with a history of thyroid cancer

How does the potential impact of GLP-1 agonists on thyroid C-cells influence prescribing decisions for patients with a family history of medullary thyroid cancer or multiple endocrine neoplasia

The presence of GLP-1R in the phylogenetically oldest parts of the brain but not in the cortex emphasizes that GLP-1 is involved in the regulation of vital functions like feeding and satiety (141)

When healthy behaviors become part of a routine rather than a temporary program, long-term success becomes more achievable

4.1 Glycaemic control outcomes Meta-analyses indicate that once-weekly GLP-1 receptor agonists provide more HbA1c reduction than twice-daily exenatide, with effectiveness similar to that of daily liraglutide (Xue et al